Cargando…

HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer

Human epidermal growth factor receptor 2 (HER2)-inhibition is an important therapeutic strategy in HER2-amplified gastro-oesophageal cancer (GOC). A significant proportion of GOC patients display HER2 amplification, yet HER2 inhibition in these patients has not displayed the success seen in HER2 amp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lote, Hazel, Valeri, Nicola, Chau, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068859/ https://www.ncbi.nlm.nih.gov/pubmed/30079142 http://dx.doi.org/10.4251/wjgo.v10.i7.159

Ejemplares similares

Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer
por: Fornaro, Lorenzo, et al.
Publicado: (2019)

Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology – an update for the surgical oncologist
por: Griffiths, Ewen A, et al.
Publicado: (2006)

Gastro-Œsophageal Intussusception
Publicado: (1935)

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
por: Shitara, Kohei, et al.
Publicado: (2022)

HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies
por: Ieni, Antonio, et al.
Publicado: (2020)

Gastro-oesophageal reflux disease and eosinophilic oesophagitis: What is the relationship?
por: Wong, Stephanie, et al.
Publicado: (2018)

Sensory Phenotype of the Oesophageal Mucosa in Gastro-Oesophageal Reflux Disease
por: Ustaoglu, Ahsen, et al.
Publicado: (2023)

Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers
por: Baxter, Mark A., et al.
Publicado: (2021)

A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers
por: Wu, C, et al.
Publicado: (2015)

Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI
por: Sharkey, Amy R., et al.
Publicado: (2021)

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer
por: Korkeila, E. A., et al.
Publicado: (2017)

Gastro-Oesophageal Reflux in Noncystic Fibrosis Bronchiectasis
por: Lee, Annemarie L., et al.
Publicado: (2011)

Is gastro-oesophageal reflux associated with COPD exacerbations?
por: Wedzicha, Jadwiga A.
Publicado: (2013)

Feed thickeners in gastro-oesophageal reflux in infants
por: Kwok, T’ng Chang, et al.
Publicado: (2018)

Serum HER 2 Extracellular Domain Level Is Correlated with Tissue HER 2 Status in Metastatic Gastric or Gastro-Oesophageal Junction Adenocarcinoma
por: Dai, Shu-Qin, et al.
Publicado: (2013)

The Evolution of Neo-Adjuvant Therapy in the Treatment of Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas
por: Dermanis, Alexander A., et al.
Publicado: (2023)

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer
por: Crumley, A B C, et al.
Publicado: (2006)

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
por: Smyth, Elizabeth C, et al.
Publicado: (2021)

Gastro-oesophageal reflux disease in children: NICE guidance
por: Davies, Ieuan, et al.
Publicado: (2015)

Carcinoma of gastro-oesophageal junction in a pregnant woman
por: Kozak, Katarzyna, et al.
Publicado: (2018)

Letter: studies of salivary pepsin in patients with gastro‐oesophageal reflux disease
por: Dettmar, Peter William, et al.
Publicado: (2019)

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
por: Feilchenfeldt, J, et al.
Publicado: (2015)

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
por: Feilchenfeldt, J, et al.
Publicado: (2015)

Endoscopic ultrasound staging in patients with gastro-oesophageal cancers: a systematic review of economic evidence
por: Yeo, Seow Tien, et al.
Publicado: (2019)

Systematic review of the introduction and evaluation of magnetic augmentation of the lower oesophageal sphincter for gastro‐oesophageal reflux disease
por: Kirkham, E. N., et al.
Publicado: (2019)

Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
por: von Loga, Katharina, et al.
Publicado: (2020)

The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction
por: Curtis, Nathan J, et al.
Publicado: (2014)

The impact of operative approach on outcome of surgery for gastro-oesophageal tumours
por: Suttie, Stuart A, et al.
Publicado: (2007)

Some of the effective factors in the pathogenesis of gastro‐oesophageal reflux disease
por: Nejat Pish‐Kenari, Fatemeh, et al.
Publicado: (2018)

Neoplastic and pre-neoplastic lesions of the oesophagus and gastro-oesophageal junction
por: Grillo, Federica, et al.
Publicado: (2020)

Factors Affecting Intraoperative Gastro-Oesophageal Reflux in Dogs and Cats
por: Savvas, Ioannis, et al.
Publicado: (2022)

Minimally invasive endoscopic therapies for gastro-oesophageal reflux disease
por: Aslam, Nasar, et al.
Publicado: (2023)

Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers – a new active regimen
por: Slater, S, et al.
Publicado: (2002)

Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.
por: Melcher, A. A., et al.
Publicado: (1996)

Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program
por: Cassier, Philippe A., et al.
Publicado: (2021)

Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial
por: Pearce, Jessica, et al.
Publicado: (2022)

Gastro-oesophageal reflux — initial experience with a radiotelemetry system for prolonged oesophageal pH monitoring
por: Collins, B J, et al.
Publicado: (1985)

There is no correlation between signs of reflux laryngitis and reflux oesophagitis in patients with gastro-oesophageal reflux disease symptoms
por: Zelenik, K., et al.
Publicado: (2017)

A Systematic Review of the Methods of Assessment of Gastro-Oesophageal Reflux in Anaesthetized Dogs
por: Fernandez Alasia, Anna Carolina, et al.
Publicado: (2021)

The prevalence of dental erosion in Nigerian patients with gastro-oesophageal reflux disease
por: Oginni, Adeleke O, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ebr5v2bfnpojfin7su15d04t29